- Home
- PDYN vs CRDF Comparison
PDYN vs CRDF Comparison
Compare PDYN & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDYN
- CRDF
- Stock Information
- Founded
- PDYN 1983
- CRDF 1999
- Country
- PDYN United States
- CRDF United States
- Employees
- PDYN N/A
- CRDF N/A
- Industry
- PDYN Wholesale Distributors
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PDYN Industrials
- CRDF Health Care
- Exchange
- PDYN Nasdaq
- CRDF Nasdaq
- Market Cap
- PDYN 160.5M
- CRDF 133.5M
- IPO Year
- PDYN N/A
- CRDF N/A
- Fundamental
- Price
- PDYN $3.54
- CRDF $5.35
- Analyst Decision
- PDYN
- CRDF Strong Buy
- Analyst Count
- PDYN 0
- CRDF 3
- Target Price
- PDYN N/A
- CRDF $10.33
- AVG Volume (30 Days)
- PDYN 10.0M
- CRDF 3.9M
- Earning Date
- PDYN 11-13-2024
- CRDF 11-07-2024
- Dividend Yield
- PDYN N/A
- CRDF N/A
- EPS Growth
- PDYN N/A
- CRDF N/A
- EPS
- PDYN N/A
- CRDF N/A
- Revenue
- PDYN $7,771,000.00
- CRDF $688,000.00
- Revenue This Year
- PDYN N/A
- CRDF $23.78
- Revenue Next Year
- PDYN $583.33
- CRDF N/A
- P/E Ratio
- PDYN N/A
- CRDF N/A
- Revenue Growth
- PDYN N/A
- CRDF 49.57
- 52 Week Low
- PDYN $0.45
- CRDF $1.30
- 52 Week High
- PDYN $7.93
- CRDF $6.42
- Technical
- Relative Strength Index (RSI)
- PDYN 48.21
- CRDF 77.18
- Support Level
- PDYN $3.27
- CRDF $3.06
- Resistance Level
- PDYN $4.40
- CRDF $4.20
- Average True Range (ATR)
- PDYN 0.97
- CRDF 0.42
- MACD
- PDYN -0.22
- CRDF 0.26
- Stochastic Oscillator
- PDYN 5.89
- CRDF 91.43
About PDYN Palladyne AI Corp. Common Stock
Palladyne AI Corp is a software company focused on autonomy for robotic systems. Its artificial intelligence and machine learning software seeks to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in a manner akin to human intelligence. AI and ML software platform empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. Palladyne AI software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing.
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").